Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
full texts were accessed in RCTs, systematic reviews, real-world cohort studies, and policy/cost-effectiveness reports
By geography, North America commanded 39.53% share in 2025, but Asia-Pacific is projected to register a 35.21% CAGR, the fastest among all regions
Other notable side effects include injection site reactions, fatigue, and headache
What is the best course of action
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP-1/GIP receptor agonist (BGM0504) in healthy volunteers: a dose-escalation phase I study
US$ 25.07
US$ 28.33
US$ 23.95
US$ 27.14
US$ 22.32
US$ 25.05
